Lots of talk of don’t know what SP will do, i will be buying more tom whether the price goes up down left or right.I think its starts big climb up. As someone else mentioned shorts pounded SP down since $5+ they now got what they wanted with Nadar out time to cover and move onto a stock that will be as transparent as CYDY was with nadar. I think PR conference calls will be a thing of the past. I believe in the science and i think todays announcement makes a partnership and or buyout a much close reality than when CYDY was looked at as long term investment - cydy going to do it all themselves headed toward slowly growing into big pharma themselves when Nadar was CEO. Now i think with NASH data as good as it is this was a necessary step from the board to make a partnership a fast reality or buyout. We all know Nadar would not entertain $15 share not long ago when only had HIV in back pocket, now we have Covid severe, Covid Critical, MNTBC, and NASH.

“Big pharma is already starting to evolve to being more focused on late-stage development and commercialization. There’s data out there showing that of the recent molecules many big pharma companies launched over the past five years, often around 90% of them have a very significant component that came from the outside. It’s a strong dynamic for the future”

90% of drugs launched in past 5 years have basically come from small biotechs like cydy. Some bought out upwards 30 billion for drugs half as safe and 1/10 of the potential of Leronlimab.

https://www.rbccm.com/en/gib/biopharma/episod...artnership